

Company's Profile
Established: | 2016 |
Line of Business: | Healthcare |
Address: | 150 Menachem Begin Rd., Tel Aviv |
Website: | http://www.viz.ai |
Facebook: | Click to View |
Twitter: | Click to View |
Linkedin: | Click to View |

Company Executives
-
Dina Begun
Data & Analytics Manager
Viz.ai
-
David Golan
CTO & Cofounder
Viz.ai
-
Shiran Dikman
Director of Software Engineering
Viz.ai
-
Uriya Weiss
Finance Manager
Viz.ai
-
Shelly Yehezkely
Director of AI
Viz.ai
-
Rotem Kaner
Director of Program Management
Viz.ai
-
Adi Levy
People Operations Manager
Viz.ai
-
Gad Sakin
CPO & GM Israel
Viz.ai
-
Or Shanoon
Director of Product Management
Viz.ai

About Viz.ai
Viz.ai is the leader in AI-driven intelligent care coordination and AI powered stroke detection and triage. Viz.ai provides outstanding services to almost 900 hospitals, ranging from smaller medical facilities to some of the largest, most respected hospital networks in the world. To date, Viz.ai has received over $150 million in private funding.
The company’s mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment, improve access to care, and increase the speed of diffusion of medical innovation.
Viz.ai’s employee base includes a wide range of specialties, from physicians, former directors of neuroscience and trained nurses, to software engineers, AI researchers, and UX designers. The company was recently granted a CE mark, which will enable it to market and sell its products in Europe. This will expand to other continents in 2022.
Viz.ai was founded in 2016 by Dr. Chris Mansi and David Golan. While Dr. Mansi was practicing as a neurosurgeon in the U.K., he saw firsthand how surgery could go well, yet the patient could still die, because too much time had passed before getting to the operating room. In 2016, while working on an M.B.A. at Stanford Business School in California, Dr. Mansi met David Golan, an Israeli machine-learning postdoc, who had recently been discharged from the hospital after a suspected stroke. Dr. Mansi and David Golan bonded over the lack of data to drive better medical decisions and pitched their idea to improve stroke care in a class run by former Google CEO Eric Schmidt, who offered seed funding through his firm Innovation Endeavors. From that idea, Viz.ai was born.
The company’s products include Viz LVO, which, leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist, who can intervene and treat the patients. In addition, Viz offers Viz CTP, which uses advanced imaging technology to automatically analyze CT perfusion images of the brain, produce parametric color maps, and calculate CT perfusion parameters. Furthermore, the company provides Viz ICH, an automated Detection & Alert of Suspected ICH; Automated ICH workflow and triage, and mobile DICOM image viewer. The company also offers Viz PE, which provides Automated Detection and Alerts of Suspected Pulmonary Embolism; AI-powered suspected pulmonary embolism detection; Intelligent activation of PERT team; Automated PE workflow, and a High-fidelity mobile image viewer, in addition to Full-stack, HIPAA-compliant communication. Moreover, Viz created Viz Aortic, a Module that enables visualization of aortic imaging on a mobile device to quickly and easily coordinate both emergent and elective care for patients. The AI-powered module detects Type A and Type B Aortic Dissections (TBAD). All aortic pathologies- including abdominal aortic disease, are available on the mobile app.
Viz.ai is currently expanding its AI product line beyond stroke into various disease states, which the company plans to roll out in the very near future.
The company’s corporate responsibility program includes the free use of its software in select underprivileged communities across the US.

Facebook Updates

Photo Gallery















You may also like
-
DUN'S 100
The 2022 in the field of taxation Forum
On February 7, 2022, we held the Duns 100 forum for senior taxation executives
The 2022 in the field of taxation Forum
-
DUN'S 100
The 2022 Leaders in Law Forum
On February 23, 2002, we held the Duns 100 Forum for Senior Legal Professionals.
The 2022 Leaders in Law Forum
-
DUN'S 100
High–tech legal forum 2022
On Wednesday, March 9, 2002, the Royal Beach Hotel Tel Aviv hosted the annual Duns 100 forum of senior Israeli legal professionals in the high-tech field with the participation of senior Dun & Bradstreet executives in Israel, Ami Applebaum, Chairman of the Innovation Authority and Chief Scientist at the Ministry of Economy.
High–tech legal forum 2022